CLINICAL_TRIALS ClinicalTrials.gov record update

Study Comparing the Immunogenicity and Reactogenicity of GSK Biologicals' HBV-MPL Vaccine Injected According to a 0, 6 Months Schedule With That of Engerix™-B Injected as a 0, 1, 6 Months Schedule in a Healthy Adult Population (15-40 Years)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00697216
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:34:55.099033+00:00
Published At: 2008-06-13T00:00:00+00:00
Record Updated At: 2008-06-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2008-06-13"
protocolSection.identificationModule.nctId: "NCT00697216"
protocolSection.identificationModule.officialTitle: "Study Comparing the Immunogenicity and Reactogenicity of GSK Biologicals\u0027 HBV-MPL Vaccine Injected According to a 0, 6 Months Schedule With That of Engerix\u2122-B Injected as a 0, 1, 6 Months Schedule in a Healthy Adult Population (15-40 Years)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.